Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2Unknown 1Recruiting 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 1

Conditions

Keratosis, Actinic 22Carcinoma, Basal Cell 10Uterine Cervical Dysplasia 7Melanoma 7Breast Neoplasms 4Uterine Cervical Neoplasms 3Precancerous Conditions 3Keratosis 3Glioma 3Glioblastoma 3Condylomata Acuminata 3Urinary Bladder Neoplasms 2Squamous Intraepithelial Lesions 2Papillomavirus Infections 2Non-Muscle Invasive Bladder Neoplasms 2Neoplasm Metastasis 2Hutchinson's Melanotic Freckle 2HIV Infections 2Astrocytoma 2Warts 1Vulvar Neoplasms 1Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) 1Virus Diseases 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sialorrhea 1Sexually Transmitted Diseases 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Gemcitabine 74Capecitabine 60Paclitaxel 59Fluorouracil 58Oxaliplatin 57Bevacizumab 51Docetaxel 50Leucovorin 48Nivolumab 40Cisplatin 40Irinotecan 39Carboplatin 37Cetuximab 34pembrolizumab 32Radiosurgery 32Trastuzumab 30Radiotherapy 27Everolimus 24Sorafenib 23Pemetrexed 20Doxorubicin 20Albumin-Bound Paclitaxel 20Ipilimumab 19Cyclophosphamide 19Panitumumab 18Zoledronic Acid 17Lapatinib 17Erlotinib Hydrochloride 17Prednisone 16pazopanib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neoplasm Metastasis × Imiquimod × Clear all
NCT02234921 2018-10-11

DRibble

UbiVac

Phase 1 Completed
3 enrolled

Adenocarcinoma, Neoplasm Metastasis, Sialorrhea

NCT00453050 2015-05-06

Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin

National Cancer Institute (NCI)

Phase 1 Completed
11 enrolled
Dermatologic

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡